|
RWDD4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6251444634463E-12 |
| Normal-vs-Stage2 |
1.22970000004941E-06 |
| Normal-vs-Stage3 |
3.99680288865056E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.702400E-03 |
| Stage1-vs-Stage3 |
6.234000E-01 |
| Stage1-vs-Stage4 |
6.036000E-04 |
| Stage2-vs-Stage3 |
6.179600E-03 |
| Stage2-vs-Stage4 |
4.31290000002527E-06 |
| Stage3-vs-Stage4 |
3.036400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.07160000043061E-07 |
| Normal-vs-Asian |
1.43218770176645E-14 |
| Caucasian-vs-AfricanAmerican |
3.181200E-01 |
| Caucasian-vs-Asian |
8.807200E-01 |
| AfricanAmerican-vs-Asian |
4.825000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.056800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.69730896004694E-12 |
| Normal-vs-Age(81-100Yrs) |
1.565440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.901600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.583610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.427200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.510200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.635200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.939600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.599700E-04 |
| Classical-VS-Follicular |
2.69619999992976E-07 |
| Classical-VS-Other |
7.045000E-01 |
| Classical-VS-Normal |
1.62558855265615E-12 |
| Tall-VS-Follicular |
5.32039967637843E-11 |
| Tall-VS-Other |
4.189400E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
5.633900E-02 |
| Follicular-VS-Normal |
1.76640000004724E-06 |
| Other-VS-Normal |
8.03120000000268E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66133814775094E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.89597999999958E-05 |
|
|
